Table 1. mRNA expression of MKPs in biopsies from human skeletal muscle and adipose tissue at baseline
MKPsAlternative nameSkeletal muscleAdipose tissue
ControlDysglycemicControlDysglycemic
DUSP1MKP‐148.41 ± 12.4851.43 ± 7.5263.03 ± 10.1568.67 ± 7.30
DUSP7PYSr29.42 ± 0.699.94 ± 0.768.64 ± 0.548.06 ± 0.27
DUSP10MKP‐56.64 ± 0.357.91 ± 0.993.13 ± 0.34 4.32 ± 0.31
DUSP6MKP‐33.20 ± 0.263.30 ± 0.3735.78 ± 1.9330.98 ± 1.86
DUSP16MKP‐73.03 ± 0.113.13 ± 0.104.67 ± 0.204.56 ± 0.22
DUSP8hVH‐52.67 ± 0.262.83 ± 0.202.89 ± 0.313.51 ± 0.20
DUSP2PAC10.38 ± 0.050.35 ± 0.030.85 ± 0.271.07 ± 0.17
DUSP4MKP‐20.22 ± 0.03 0.38 ± 0.08 25.43 ± 3.46 13.39 ± 1.43
DUSP5VH30.27 ± 0.050.22 ± 0.021.94 ± 0.171.89 ± 0.15
  • Comparison of MKPs expression between the control (n = 11) and dysglycemic group (n = 13) at baseline in biopsies from human skeletal muscle and adipose tissue. Values represent means FPKM ± SEM; P‐values were calculated by unpaired Student's t‐test, P < 0.05 versus control group (bold). MKPs, MAPK phosphatases; DUSP, dual specificity phosphatase; FPKM, fragments per kB mapped reads.